AMP激酶:在COVID-19后的并发症中是一个有前途的治疗药物标
Mohammad Saquib Ashraf1, Kanika Tuli2, Shadman Moiz3
1Department of Medical Laboratory Science College of Pharmacy, Nursing and Medical Science Riyadh ELM University, Riyadh, P.O. Box 12734, Saudi Arabia.
Life sciences
|November 3, 2024
概括
通过抑制AMPK,COVID-19通过抑制AMPK来破坏葡萄糖代谢. 用天然化合物激活AMPK可以预防COVID-19后的糖尿病和心血管问题,改善患者的治疗结果.
科学领域:
- 生物化学 生物化学
- 代谢障碍 代谢障碍 代谢障碍
- 病毒学 病毒学
背景情况:
- COVID-19 (SARS-CoV-2) 导致严重的呼吸系统疾病和代谢并发症,包括糖尿病和非糖尿病患者的葡萄糖代谢恶化.
- AMP激活蛋白激酶 (AMPK) 对于细胞能量至关重要,调节葡萄糖代谢,胰岛素敏感性和炎症.
- 感染SARS-CoV-2抑制AMPK,导致代谢失调和持续的COVID-19后并发症.
研究的目的:
- 审查AMPK激活机制及其在代谢障碍中的作用.
- 探索天然化合物作为潜在的AMPK激活剂,用于管理COVID-19后的并发症.
- 研究激活AMPK以预防COVID-19后糖尿病和心血管问题的方法.
主要方法:
- 关于AMPK,SARS-CoV-2,代谢障碍和自然化合物效应的研究文献综述.
- 分析AMPK在葡萄糖吸收,脂肪酸氧化和自中的作用.
- 检查AMPK激活剂,如西类药物,黄素和甲胺.
主要成果:
- SARS-CoV-2 抑制AMPK,导致代谢功能障碍.
- 各种天然化合物 (素,黄素等). 和甲福明显示出调节AMPK活性的潜力.
- AMPK激活会影响葡萄糖代谢,胰岛素敏感性和炎症反应.
结论:
- 准AMPK激活是缓解COVID-19长期影响的有希望的策略.
- 自然化合物为COVID-19后代谢并发症提供了潜在的治疗途径.
- 激活AMPK可能有助于预防COVID-19感染后的糖尿病和心血管问题.
相关概念视频
01:14Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
01:07MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
01:25cAMP-dependent Protein Kinase Pathways
6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
142
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
142
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K